BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38447759)

  • 1. Binding of the monoacylglycerol lipase (MAGL) radiotracer [
    Mikkelsen JD; Aripaka SS; Egilmez CB; Pazarlar BA
    Neurochem Int; 2024 May; 175():105717. PubMed ID: 38447759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatio-Temporal Alterations in Synaptic Density During Epileptogenesis in the Rat Brain.
    Mikkelsen JD; Aripaka SS; Bascuñana P; Bankstahl M; Bankstahl JP; Pazarlar BA
    Neuroscience; 2022 Sep; 499():142-151. PubMed ID: 35878719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal and spatial changes in synaptic vesicle glycoprotein 2A (SV2A) under kainic acid induced epileptogenesis: An autoradiographic study.
    Pazarlar BA; Madsen CA; Oyar EÖ; Eğilmez CB; Mikkelsen JD
    Epilepsy Res; 2022 Jul; 183():106926. PubMed ID: 35526328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet.
    Terrone G; Pauletti A; Salamone A; Rizzi M; Villa BR; Porcu L; Sheehan MJ; Guilmette E; Butler CR; Piro JR; Samad TA; Vezzani A
    Epilepsia; 2018 Jan; 59(1):79-91. PubMed ID: 29171003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor.
    Wyatt RM; Fraser I; Welty N; Lord B; Wennerholm M; Sutton S; Ameriks MK; Dugovic C; Yun S; White A; Nguyen L; Koudriakova T; Tian G; Suarez J; Szewczuk L; Bonnette W; Ahn K; Ghosh B; Flores CM; Connolly PJ; Zhu B; Macielag MJ; Brandt MR; Chevalier K; Zhang SP; Lovenberg T; Bonaventure P
    J Pharmacol Exp Ther; 2020 Mar; 372(3):339-353. PubMed ID: 31818916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of (
    He Y; Krämer SD; Grether U; Wittwer MB; Collin L; Kuhn B; Topp A; Heer D; O'Hara F; Honer M; Pavlovic A; Richter H; Ritter M; Rombach D; Keller C; Gobbi L; Mu L
    J Nucl Med; 2024 Feb; 65(2):300-305. PubMed ID: 38164615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory nausea in rat models.
    Parker LA; Limebeer CL; Rock EM; Sticht MA; Ward J; Turvey G; Benchama O; Rajarshi G; Wood JT; Alapafuja SO; Makriyannis A
    Psychopharmacology (Berl); 2016 Jun; 233(12):2265-75. PubMed ID: 27048155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High Specificity.
    Zhang L; Butler CR; Maresca KP; Takano A; Nag S; Jia Z; Arakawa R; Piro JR; Samad T; Smith DL; Nason DM; O'Neil S; McAllister L; Schildknegt K; Trapa P; McCarthy TJ; Villalobos A; Halldin C
    J Med Chem; 2019 Sep; 62(18):8532-8543. PubMed ID: 31483137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography.
    Wang C; Placzek MS; Van de Bittner GC; Schroeder FA; Hooker JM
    ACS Chem Neurosci; 2016 Apr; 7(4):484-9. PubMed ID: 26694017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intranasal and oral administration of levetiracetam on the temporal and spatial distributions of SV2A in the KA-induced rat model of SE.
    Zhao W; Li Y; Sun H; Zhang W; Li J; Jiang T; Jiang L; Meng H
    J Cell Mol Med; 2023 Dec; 27(24):4045-4055. PubMed ID: 37845841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis and evaluation of a novel monoacylglycerol lipase radiotracer: 1,1,1,3,3,3-hexafluoropropan-2-yl-3-(1-benzyl-1H-pyrazol-3-yl)azetidine-1-[
    Mori W; Hatori A; Zhang Y; Kurihara Y; Yamasaki T; Xie L; Kumata K; Hu K; Fujinaga M; Zhang MR
    Bioorg Med Chem; 2019 Aug; 27(16):3568-3573. PubMed ID: 31278005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors.
    Afzal O; Kumar S; Kumar R; Firoz A; Jaggi M; Bawa S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3986-96. PubMed ID: 25011912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of monoacylglycerol lipase and its occupancy by an exogenous ligand in rhesus monkey brains using [
    Hattori Y; Seki C; Maeda J; Nagai Y; Aoyama K; Zhang MR; Minamimoto T; Koike T; Higuchi M
    J Cereb Blood Flow Metab; 2022 Apr; 42(4):656-666. PubMed ID: 34727758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S; Ayyannan SR
    ChemMedChem; 2022 Jan; 17(1):e202100559. PubMed ID: 34637598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.
    Hicks JW; Parkes J; Tong J; Houle S; Vasdev N; Wilson AA
    Nucl Med Biol; 2014 Sep; 41(8):688-94. PubMed ID: 24969632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of diazetidinyl diamides as potent and reversible inhibitors of monoacylglycerol lipase (MAGL).
    Zhu B; Connolly PJ; Zhang SP; Chevalier KM; Milligan CM; Flores CM; Macielag MJ
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127198. PubMed ID: 32334914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
    Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
    Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.
    Gillard M; Chatelain P; Fuks B
    Eur J Pharmacol; 2006 Apr; 536(1-2):102-8. PubMed ID: 16556440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with
    Takahata K; Seki C; Kimura Y; Kubota M; Ichise M; Sano Y; Yamamoto Y; Tagai K; Shimada H; Kitamura S; Matsuoka K; Endo H; Shinotoh H; Kawamura K; Zhang MR; Takado Y; Higuchi M
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3150-3161. PubMed ID: 35022846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of carbamate derivatives as fatty acid amide hydrolase and monoacylglycerol lipase inhibitors.
    Jaiswal S; Gupta G; Ayyannan SR
    Arch Pharm (Weinheim); 2022 Nov; 355(11):e2200081. PubMed ID: 35924298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.